Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 09, 2011 16:01 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces Proposed Public Offering of Common Stock and Warrants

BOTHELL, WA--(Marketwire - February 9, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that it intends to offer and sell...
February 08, 2011 09:00 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. to Present at The 13th Annual BIO CEO & Investor Conference

BOTHELL, WA--(Marketwire - February 8, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, announced today that it will present at The 13th...
February 03, 2011 08:00 ET | Source: Marina Biotech, Inc.

Marina Biotech and The Debiopharm Group Partner to Develop and Commercialize RNAi-Based Therapies for the Treatment of Bladder Cancer

LAUSANNE, SWITZERLAND and BOTHELL, WA--(Marketwire - February 3, 2011) - The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development group of companies with a main focus in...
January 27, 2011 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces Issuance of Patent Covering Its Nucleic Acid Condensing Peptide Technology From the Japanese Patent Office

BOTHELL, WA--(Marketwire - January 27, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that the Japanese Patent Office has...
January 04, 2011 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. to Present at Biotech Showcase 2011

BOTHELL, WA--(Marketwire - January 4, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, announced today that it will present at Biotech...
January 03, 2011 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces Allowance of Patent Covering DiLA2 Delivery Platform From U.S. Patent Office

BOTHELL, WA--(Marketwire - January 3, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that the U.S. Patent and Trademark...
December 29, 2010 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Receives Orphan Drug Status Designation for CEQ508 for the Treatment of Familial Adenomatous Polyposis

BOTHELL, WA--(Marketwire - December 29, 2010) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that the U.S. Food and Drug...
December 17, 2010 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces Allowance of European Patent Covering Its Proprietary Peptide-siRNA Conjugate Delivery Platform

BOTHELL, WA--(Marketwire - December 17, 2010) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that the European Patent Office...
December 13, 2010 09:00 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. to Participate in RodmanTV Analyst Discussion

BOTHELL, WA--(Marketwire - December 13, 2010) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, announced today that it will participate in an analyst...
November 24, 2010 16:10 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. to Present at 22nd Annual Piper Jaffray Health Care Conference

BOTHELL, WA--(Marketwire - November 24, 2010) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, announced today that it will present at the 22nd...